help button home button Endocrine Society JCEM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Article
Right arrow Full Text (PDF)
Right arrow Submit a related Letter to the Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Conover, C. A.
Right arrow Articles by Jensen, M. D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Conover, C. A.
Right arrow Articles by Jensen, M. D.

Journal of Clinical Endocrinology & Metabolism, Vol 74, 1355-1360, Copyright © 1992 by Endocrine Society

ARTICLES

Insulin regulation of insulin-like growth factor binding protein-1 in obese and nonobese humans

CA Conover, PD Lee, JA Kanaley, JT Clarkson and MD Jensen
Endocrine Research Unit, Mayo Clinic, Rochester, Minnesota 55905.

Insulin is the principal regulator of hepatic insulin-like growth factor binding protein-1 (IGFBP-1) production, mediating the rapid decrease in plasma IGFBP-1 in response to nutritional intake. In this study, we defined IGFBP-1 regulation by insulin in upper and lower body obesity, conditions associated with insulin resistance and chronic hyperinsulinemia. Overnight postabsorptive IGFBP-1 levels in obese and nonobese women showed an inverse, nonlinear relationship with plasma insulin concentrations. Maximum suppression of IGFBP-1 was seen at 70- 90 pmol/L plasma insulin. Both groups of obese women had mean fasting plasma insulin concentrations above this threshold level and, consequently, markedly suppressed IGFBP-1 levels. To assess the dynamics of insulin regulated IGFBP-1, 10 obese and 8 nonobese women were studied during sequential saline infusion (0-90 min), hyperinsulinemia (insulin infusion; 90-210 min) and hypoinsulinemia (somatostatin + GH infusion; 210-330 min). Insulin infusion rapidly decreased plasma IGFBP-1 levels in nonobese subjects (60% decrease in 2 h), but had little or no further suppressive effect in obese subjects. Complete insulin withdrawal resulted in a significant rise in plasma IGFBP-1 concentrations in all subjects, but the response was blunted in obese compared to nonobese groups. In contrast to plasma IGFBP-1, IGF-I concentrations did not vary during hyper- and hypoinsulinemic infusion periods and were not significantly different between groups. Basal GH levels were significantly higher in nonobese when compared to obese women, but did not change with infusions. In conclusion, low IGFBP-1 levels in obesity are related to elevated insulin levels which are, in turn, related to body fat distribution and insulin resistance. The chronically depressed levels of IGFBP-1 may promote IGF bioactivity as well as its feedback regulation of GH secretion, thus contributing to the metabolic and mitogenic consequences of obesity. In addition, our findings imply that hepatic insulin sensitivity in terms of IGFBP-1 production is preserved despite peripheral insulin resistance in obesity.


This article has been cited by other articles:


Home page
 J. Clin. Endocrinol. Metab.Home page
J. Frystyk, D. J. Brick, A. V. Gerweck, A. L. Utz, and K. K. Miller
Bioactive Insulin-Like Growth Factor-I in Obesity
J. Clin. Endocrinol. Metab., August 1, 2009; 94(8): 3093 - 3097.
[Abstract] [Full Text] [PDF]

Home page
 Eur J EndocrinolHome page
P. Holland-Fischer, H. Vilstrup, J. Frystyk, D. T. Nielsen, A. Flyvbjerg, and H. Gronbaek
The IGF system after insertion of a transjugular intrahepatic porto-systemic shunt in patients with liver cirrhosis
Eur. J. Endocrinol., June 1, 2009; 160(6): 957 - 963.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Clin. Nutr.Home page
W. Wen, X. O. Shu, H. Li, G. Yang, B.-T. Ji, H. Cai, Y.-T. Gao, and W. Zheng
Dietary carbohydrates, fiber, and breast cancer risk in Chinese women
Am. J. Clinical Nutrition, January 1, 2009; 89(1): 283 - 289.
[Abstract] [Full Text] [PDF]

Home page
 Endocr. Rev.Home page
A. A. Samani, S. Yakar, D. LeRoith, and P. Brodt
The Role of the IGF System in Cancer Growth and Metastasis: Overview and Recent Insights
Endocr. Rev., February 1, 2007; 28(1): 20 - 47.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Epidemiol. Biomarkers Prev.Home page
A. H. Eliassen, S. S. Tworoger, C. S. Mantzoros, M. N. Pollak, and S. E. Hankinson
Circulating Insulin and C-Peptide Levels and Risk of Breast Cancer among Predominately Premenopausal Women
Cancer Epidemiol. Biomarkers Prev., January 1, 2007; 16(1): 161 - 164.
[Abstract] [Full Text] [PDF]

Home page
 J Child NeurolHome page
F. Mujgan Sonmez, E. Demir, A. Orem, S. Yildirmis, F. Orhan, A. Aslan, and M. Topbas
Effect of Antiepileptic Drugs on Plasma Lipids, Lipoprotein (a), and Liver Enzymes
J Child Neurol, January 1, 2006; 21(1): 70 - 74.
[Abstract] [PDF]

Home page
 Eur J EndocrinolHome page
U. Espelund, J. M. Bruun, B. Richelsen, A. Flyvbjerg, and J. Frystyk
Pro- and mature IGF-II during diet-induced weight loss in obese subjects
Eur. J. Endocrinol., December 1, 2005; 153(6): 861 - 869.
[Abstract] [Full Text] [PDF]

Home page
 Eur J OrthodHome page
A. Sadeghianrizi, C.-M. Forsberg, C. Marcus, and G. Dahllof
Craniofacial development in obese adolescents
Eur J Orthod, December 1, 2005; 27(6): 550 - 555.
[Abstract] [Full Text] [PDF]

Home page
 Hum Reprod UpdateHome page
E. Diamanti-Kandarakis and C. Piperi
Genetics of polycystic ovary syndrome: searching for the way out of the labyrinth
Hum. Reprod. Update, November 1, 2005; 11(6): 631 - 643.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Epidemiol. Biomarkers Prev.Home page
T. O. Keku, P. K. Lund, J. Galanko, J. G. Simmons, J. T. Woosley, and R. S. Sandler
Insulin Resistance, Apoptosis, and Colorectal Adenoma Risk
Cancer Epidemiol. Biomarkers Prev., September 1, 2005; 14(9): 2076 - 2081.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Epidemiol. Biomarkers Prev.Home page
A. V. Patel, C. Rodriguez, L. Bernstein, A. Chao, M. J. Thun, and E. E. Calle
Obesity, Recreational Physical Activity, and Risk of Pancreatic Cancer In a Large U.S. Cohort
Cancer Epidemiol. Biomarkers Prev., February 1, 2005; 14(2): 459 - 466.
[Abstract] [Full Text] [PDF]

Home page
 J. Nutr.Home page
T. G. Nielsen, A. Olsen, J. Christensen, K. Overvad, and A. Tjonneland
Dietary Carbohydrate Intake Is Not Associated with the Breast Cancer Incidence Rate Ratio in Postmenopausal Danish Women
J. Nutr., January 1, 2005; 135(1): 124 - 128.
[Abstract] [Full Text] [PDF]

Home page
 Diabetes CareHome page
K. Kaushal, A. H. Heald, K. W. Siddals, M. S. Sandhu, D. B. Dunger, J. M. Gibson, and N. J. Wareham
The Impact of Abnormalities in IGF and Inflammatory Systems on the Metabolic Syndrome
Diabetes Care, November 1, 2004; 27(11): 2682 - 2688.
[Abstract] [Full Text] [PDF]

Home page
 NeurologyHome page
J. I. T. Isojarvi
Reproductive dysfunction in women with epilepsy
Neurology, September 1, 2003; 61(90062): S27 - 34.
[Abstract] [Full Text]

Home page
 J. Clin. Endocrinol. Metab.Home page
H. Norrelund, J. Frystyk, J. O. L. Jorgensen, N. Moller, J. S. Christiansen, H. Orskov, and A. Flyvbjerg
The Effect of Growth Hormone on the Insulin-Like Growth Factor System during Fasting
J. Clin. Endocrinol. Metab., July 1, 2003; 88(7): 3292 - 3298.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Epidemiol. Biomarkers Prev.Home page
C. R. Jonas, M. L. McCullough, L. R. Teras, K. A. Walker-Thurmond, M. J. Thun, and E. E. Calle
Dietary Glycemic Index, Glycemic Load, and Risk of Incident Breast Cancer in Postmenopausal Women
Cancer Epidemiol. Biomarkers Prev., June 1, 2003; 12(6): 573 - 577.
[Abstract] [Full Text] [PDF]

Home page
 Diabetes CareHome page
K. B. Michels, C. G. Solomon, F. B. Hu, B. A. Rosner, S. E. Hankinson, G. A. Colditz, and J. E. Manson
Type 2 Diabetes and Subsequent Incidence of Breast Cancer in the Nurses' Health Study
Diabetes Care, June 1, 2003; 26(6): 1752 - 1758.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Epidemiol. Biomarkers Prev.Home page
S. H. Saydah, E. A. Platz, N. Rifai, M. N. Pollak, F. L. Brancati, and K. J. Helzlsouer
Association of Markers of Insulin and Glucose Control with Subsequent Colorectal Cancer Risk
Cancer Epidemiol. Biomarkers Prev., May 1, 2003; 12(5): 412 - 418.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
M. M. Buijs, J. Burggraaf, J. G. Langendonk, R. C. Schoemaker, M. Frolich, J.-W. Arndt, A. F. Cohen, J. A. Romijn, M. T. Ackermans, H. P. Sauerwein, et al.
Hyposomatotropism Blunts Lipolysis in Abdominally Obese Women
J. Clin. Endocrinol. Metab., August 1, 2002; 87(8): 3851 - 3858.
[Abstract] [Full Text] [PDF]

Home page
 DiabetesHome page
A. H. Heald, K.W. Siddals, W. Fraser, W. Taylor, K. Kaushal, J. Morris, R. J. Young, A. White, and J. M. Gibson
Low Circulating Levels of Insulin-Like Growth Factor Binding Protein-1 (IGFBP-1) Are Closely Associated With the Presence of Macrovascular Disease and Hypertension in Type 2 Diabetes
Diabetes, August 1, 2002; 51(8): 2629 - 2636.
[Abstract] [Full Text] [PDF]

Home page
 JNCI J Natl Cancer InstHome page
M. S. Sandhu, D. B. Dunger, and E. L. Giovannucci
Insulin, Insulin-Like Growth Factor-I (IGF-I), IGF Binding Proteins, Their Biologic Interactions, and Colorectal Cancer
J Natl Cancer Inst, July 3, 2002; 94(13): 972 - 980.
[Abstract] [Full Text] [PDF]

Home page
 Ann OncolHome page
B. A. Stoll
Oestrogen/insulin-like growth factor-I receptor interaction in early breast cancer: clinical implications
Ann. Onc., February 20, 2002; 13(2): 191 - 196.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
L. Gianotti, A. I. Pincelli, M. Scacchi, M. Rolla, D. Bellitti, E. Arvat, F. Lanfranco, A. Torsello, E. Ghigo, F. Cavagnini, et al.
Effects of Recombinant Human Insulin-Like Growth Factor I Administration on Spontaneous and Growth Hormone (GH)-Releasing Hormone-Stimulated GH Secretion in Anorexia Nervosa
J. Clin. Endocrinol. Metab., August 1, 2000; 85(8): 2805 - 2809.
[Abstract] [Full Text]

Home page
 J. Clin. Endocrinol. Metab.Home page
H. J. H. M. T. van Dessel, P. D. K. Lee, G. Faessen, B. C. J. M. Fauser, and L. C. Giudice
Elevated Serum Levels of Free Insulin-Like Growth Factor I in Polycystic Ovary Syndrome
J. Clin. Endocrinol. Metab., September 1, 1999; 84(9): 3030 - 3035.
[Abstract] [Full Text]

Home page
 J. Clin. Endocrinol. Metab.Home page
N. Attia, W. V. Tamborlane, R. Heptulla, D. Maggs, A. Grozman, R. S. Sherwin, and S. Caprio
The Metabolic Syndrome and Insulin-Like Growth Factor I Regulation in Adolescent Obesity
J. Clin. Endocrinol. Metab., May 1, 1998; 83(5): 1467 - 1471.
[Abstract] [Full Text]

Home page
 J. Clin. Endocrinol. Metab.Home page
D. Haffner, W. F. Blum, U. Heinrich, O. Mehls, and B. Tonshoff
Impaired Postprandial Regulation of Insulin-Like Growth Factor Binding Protein-1 in Children with Chronic Renal Failure
J. Clin. Endocrinol. Metab., September 1, 1997; 82(9): 2832 - 2835.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
J. Argente, N. Caballo, V. Barrios, J. Pozo, M. T. Munoz, J. A. Chowen, and M. Hernandez
Multiple Endocrine Abnormalities of the Growth Hormone and Insulin-Like Growth Factor Axis in Prepubertal Children with Exogenous Obesity: Effect of Short- and Long-Term Weight Reduction
J. Clin. Endocrinol. Metab., July 1, 1997; 82(7): 2076 - 2083.
[Abstract] [Full Text] [PDF]

Home page
 EndocrinologyHome page
E. Melian, B. Velasco, R. Barrios, and F. Sanchez-Franco
Basal and Growth Hormone-Induced Hepatic Messenger Ribonucleic Acid Expression of Insulin-Like Growth Factor-I (IGF-I) and IGF-Binding Protein-3 Is Independent of Hyperinsulinemia and Increased Energy Status in the Genetically Obese Zucker Rat
Endocrinology, March 1, 1997; 138(3): 1066 - 1071.
[Abstract] [Full Text] [PDF]

Home page
 Reproductive SciencesHome page
E. Carmina, F. Z. Stanczyk, R. S. Morris, P. D. K. Lee, G. Savjani, and R. A. Lobo
Altered Regulation of Insulin-Like Growth Factor Binding Protein-I in Patients With Polycystic Ovary Syndrome
Reproductive Sciences, November 1, 1995; 2(6): 743 - 747.
[Abstract] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 1992 by The Endocrine Society